Search Close Search

Lead investigators:
yellow line

Apurv Soni, MD, PhD, Laurel O'Connor, MD, John Broach, MD

The status quo:
Yellow Line

Advances in diagnostics and therapeutics have revolutionized the care of many chronic diseases. However, the implementation and accessibility of these developments often falter as they encounter the complexity of the US healthcare system. Delivering the right care, at the right time, could make a significant difference in the lives of patients with chronic conditions.

How we innovate:
Yellow Line

The Healthy at Home study evaluates the feasibility of providing the following services for up to 100 COPD patients who receive healthcare through the UMass Memorial Medicare Accountable Care Organization (UMMACO):

Virtual care program. 

A personalized, virtual care program provided by Wellinks, a private company that specializes in COPD disease management. The Wellinks program provides study participants with virtual support from a multidisciplinary clinical team that includes a health coach, respiratory therapist, nutritionist, exercise physiologist and registered nurse. The Healthy at Home study will evaluate the adoption, adherence, and efficacy of the Wellinks program.

Mobile integrated health. 

A mobile app that empowers patients to contact the Mobile Integrated Health (MIH) program, a team of paramedics that perform on-demand, in-home medical evaluations and treatments. Study participants can directly call MIH to schedule an at-home visit if they aren’t feeling well.

Wrist-based wearable sensor. 

A commercially available wrist-based wearable sensor that collects physiology data from participants over a six-month period. Our data analysis team plans to identify signals that predict worsening trends in patients’ health.

What we study:
Yellow Line

The Healthy at Home pilot study evaluates novel methods of delivering care to patients with chronic obstructive pulmonary disease (COPD). A leading cause of morbidity and mortality in the United States, COPD is characterized by chronic symptoms such as shortness of breath, coughing, and excess mucus production. Early recognition and treatment of worsening COPD symptoms and access to evidence-based interventions such as pulmonary rehabilitation are critical to improving clinical outcomes and quality of life.​

Join this study

If you are interested in learning more and participating in this study, please click the buttons below.


Interested? Learn more Contact our team

Page Menu

Healthy at Home: Creating Novel Pathways to Multidisciplinary Care